PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Vicks Sinex Decongestant nasal spray
1202020G0BCAAAA
Vicks (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Vicks Sinex Micromist nasal spray
1202020G0BCABAA
Vicks (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Vistamethasone N ear/eye/nose drops
1201010E0BCAAAB
Vistamethasone N Betamethasone sodium phosphate Ear, Nose and Oropharynx No data available
Vivabec 50micrograms/dose nasal spray
1202010C0BIAAAA
Vivabec Beclometasone dipropionate Ear, Nose and Oropharynx No data available
Vividrin 2% nasal spray (Bausch & Lomb)
1202010P0BEAAAH
Vividrin (Nasal) Sodium cromoglicate Ear, Nose and Oropharynx No data available
Vividrin 2% nasal spray (Imported)
1202010P0BEABAH
Vividrin (Nasal) Sodium cromoglicate Ear, Nose and Oropharynx No data available
Vocalzone Throat pastilles blackcurrant
1203030N0BIACA0
Vocalzone Menthol Ear, Nose and Oropharynx No data available
Vocalzone Throat pastilles honey & lemon
1203030N0BIADA0
Vocalzone Menthol Ear, Nose and Oropharynx No data available
Xerostom chewable capsules
1203050A0BIAFAR
Xerostom Artificial saliva products Ear, Nose and Oropharynx No data available
Xerostom Mucosa gel
120305000BBAZA0
Proprietary compound preparation BNF 1203050 Other treatment of dry mouth preparations Ear, Nose and Oropharynx No data available
Zubes Honey & Lemon lozenges
120303000BBBWA0
Proprietary compound preparation BNF 1203030 Other lozenge and spray preparations Ear, Nose and Oropharynx No data available
Zubes Original lozenges
120303000BBBQAH
Proprietary compound preparation BNF 1203030 Other lozenge and spray preparations Ear, Nose and Oropharynx No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.